Lauren Yallop1, Marni Brownell2, Dan Chateau3, John Walker4, Michelle Warren5, Dan Bailis6, Michael Lebow6. 1. Clinical Psychologist, Alberta Health Services, Calgary, Alberta. 2. Associate Professor, Department of Community Health Sciences (Manitoba Centre for Health Policy), College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba. 3. Assistant Professor, Department of Community Health Sciences (Manitoba Centre for Health Policy), College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba. 4. Professor, Department of Clinical Health Psychology, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba. 5. Clinical Psychologist, Manitoba Cognitive Behavioral Therapy Institute, Winnipeg, Manitoba. 6. Professor, Department of Psychology, Faculty of Arts, University of Manitoba, Winnipeg, Manitoba.
Abstract
OBJECTIVE: It has only recently been accepted that attention-deficit hyperactivity disorder (ADHD) persists into adulthood. Accordingly, less is known about adult diagnostic and treatment prevalence. We aimed to determine the lifetime prevalence of ADHD diagnosis and psychostimulant prescriptions for young adults in the province of Manitoba and to explore how diagnosis differs according to sociodemographic characteristics and age at diagnosis; and to investigate whether a socioeconomic gradient exists within young adults with a lifetime ADHD diagnosis, as well as the variables that moderate the gradient. METHODS: Using the Manitoba Population Health Research Data Repository, our cross-sectional analysis used 24 fiscal years of data (1984/85 to 2008/09) and included all adults aged 18 to 29 during 2007/08 to 2008/09 in Manitoba (n = 207 544) who had a lifetime diagnosis of ADHD (n = 14 762). Regression analyses tested for differences in rates by sex, region, age, age at diagnosis, and socioeconomic status. RESULTS: Lifetime prevalence for ADHD diagnosis (7.11%) and psychostimulant prescriptions (3.09%) differed according to sex, region, and age. In contrast to previous Manitoban research on childhood ADHD, the socioeconomic gradient for ADHD diagnosis was not found in young adulthood. When region was accounted for, a small negative gradient in the urban population and a positive gradient in the rural population were evident. People from the highest income quintile were significantly less likely to be diagnosed before age 18, compared with other income quintiles. CONCLUSIONS: Given the high lifetime prevalence of ADHD in Manitoban young adults and significant socioeconomic correlates for diagnosis, further investigation into the trajectory of this relatively unexplored population is recommended.
OBJECTIVE: It has only recently been accepted that attention-deficit hyperactivity disorder (ADHD) persists into adulthood. Accordingly, less is known about adult diagnostic and treatment prevalence. We aimed to determine the lifetime prevalence of ADHD diagnosis and psychostimulant prescriptions for young adults in the province of Manitoba and to explore how diagnosis differs according to sociodemographic characteristics and age at diagnosis; and to investigate whether a socioeconomic gradient exists within young adults with a lifetime ADHD diagnosis, as well as the variables that moderate the gradient. METHODS: Using the Manitoba Population Health Research Data Repository, our cross-sectional analysis used 24 fiscal years of data (1984/85 to 2008/09) and included all adults aged 18 to 29 during 2007/08 to 2008/09 in Manitoba (n = 207 544) who had a lifetime diagnosis of ADHD (n = 14 762). Regression analyses tested for differences in rates by sex, region, age, age at diagnosis, and socioeconomic status. RESULTS: Lifetime prevalence for ADHD diagnosis (7.11%) and psychostimulant prescriptions (3.09%) differed according to sex, region, and age. In contrast to previous Manitoban research on childhood ADHD, the socioeconomic gradient for ADHD diagnosis was not found in young adulthood. When region was accounted for, a small negative gradient in the urban population and a positive gradient in the rural population were evident. People from the highest income quintile were significantly less likely to be diagnosed before age 18, compared with other income quintiles. CONCLUSIONS: Given the high lifetime prevalence of ADHD in Manitoban young adults and significant socioeconomic correlates for diagnosis, further investigation into the trajectory of this relatively unexplored population is recommended.
Authors: Joseph Biederman; Eric Mick; Stephen V Faraone; Ellen Braaten; Alysa Doyle; Thomas Spencer; Timothy E Wilens; Elizabeth Frazier; Mary Ann Johnson Journal: Am J Psychiatry Date: 2002-01 Impact factor: 18.112
Authors: Nora D Volkow; Gene-Jack Wang; Jeffrey Newcorn; Joanna S Fowler; Frank Telang; Mary V Solanto; Jean Logan; Christopher Wong; Yeming Ma; James M Swanson; Kurt Schulz; Kith Pradhan Journal: Neuroimage Date: 2006-11-27 Impact factor: 6.556
Authors: Ronald C Kessler; Lenard Adler; Russell Barkley; Joseph Biederman; C Keith Conners; Olga Demler; Stephen V Faraone; Laurence L Greenhill; Mary J Howes; Kristina Secnik; Thomas Spencer; T Bedirhan Ustun; Ellen E Walters; Alan M Zaslavsky Journal: Am J Psychiatry Date: 2006-04 Impact factor: 18.112